M Holdings Securities, Inc. Rigel Pharmaceuticals Inc Transaction History

M Holdings Securities, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 17, 2019	SELL	$2.0 - $2.65 $60,000 - $79,500	-30,000 Closed	0 $0
Q3 2018 Nov 16, 2018	BUY	$2.6 - $3.59 $78,000 - $107,700	30,000 New	30,000 $96,000

122

110M

556K

33.9K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $1.36B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.